PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $47,000 | -35.6% | 17,798 | -43.1% | 0.00% | – |
| Q2 2018 | $73,000 | -24.0% | 31,287 | -3.8% | 0.00% | -100.0% |
| Q1 2018 | $96,000 | -32.9% | 32,513 | -37.6% | 0.00% | 0.0% |
| Q4 2017 | $143,000 | +232.6% | 52,122 | +312.9% | 0.00% | – |
| Q3 2017 | $43,000 | +38.7% | 12,623 | -0.6% | 0.00% | – |
| Q2 2017 | $31,000 | +3.3% | 12,702 | -2.8% | 0.00% | – |
| Q1 2017 | $30,000 | +7.1% | 13,064 | 0.0% | 0.00% | – |
| Q4 2016 | $28,000 | -50.9% | 13,064 | -23.0% | 0.00% | – |
| Q3 2016 | $57,000 | -14.9% | 16,970 | -20.9% | 0.00% | – |
| Q2 2016 | $67,000 | +4.7% | 21,455 | +12.4% | 0.00% | – |
| Q1 2016 | $64,000 | +20.8% | 19,088 | +27.9% | 0.00% | – |
| Q4 2015 | $53,000 | -75.9% | 14,929 | -65.8% | 0.00% | -100.0% |
| Q3 2015 | $220,000 | +478.9% | 43,660 | +641.4% | 0.00% | – |
| Q2 2015 | $38,000 | +15.2% | 5,889 | +27.3% | 0.00% | – |
| Q1 2015 | $33,000 | -5.7% | 4,625 | +0.6% | 0.00% | – |
| Q4 2014 | $35,000 | -14.6% | 4,598 | -15.5% | 0.00% | – |
| Q3 2014 | $41,000 | -24.1% | 5,441 | -1.6% | 0.00% | – |
| Q2 2014 | $54,000 | +22.7% | 5,529 | +5.3% | 0.00% | – |
| Q1 2014 | $44,000 | 0.0% | 5,252 | +0.5% | 0.00% | – |
| Q4 2013 | $44,000 | -69.0% | 5,227 | -70.6% | 0.00% | -100.0% |
| Q3 2013 | $142,000 | +91.9% | 17,801 | +86.7% | 0.00% | 0.0% |
| Q2 2013 | $74,000 | – | 9,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |